Stay updated on Pembrolizumab in SCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in SCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page revision indicator was updated to v3.6.2, replacing the previous v3.6.0. This indicates a minor internal update to the page template or content.
    Difference
    0.1%
    Check dated 2026-06-29T08:42:54.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Recruitment status on the page now shows 'No longer looking for participants,' and the Intervention/Treatment label has been standardized. New help and navigation sections—How to Read a Study Record, Common Questions, and How to Join a Study—were added, and the revision tag updated to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-15T07:54:57.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The page revision label updated from v3.5.4 to v3.5.5, indicating a refreshed version of the page.
    Difference
    0.1%
    Check dated 2026-06-08T03:50:07.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.3 to v3.5.4, indicating a new version of the page content has been published.
    Difference
    0.1%
    Check dated 2026-05-17T11:12:04.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The page’s ClinicalTrials.gov interface revision indicator was updated from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-25T18:45:29.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-18T13:38:59.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in SCLC Clinical Trial page.